Clinical Trials Browser

Observational × Immune Checkpoint Inhibitors × Thoracic × Clear all

NCT07359040 2026-03-12

Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer

Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT07434518 2026-02-25

A Real-World Study Evaluating the Efficacy and Safety of Adebrelimab in Patients With Advanced SCLC

Small Cell Lung Carcinoma

NCT07192926 2026-02-20

SARCO-CTI

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung, Neoplasms, Sarcopenia

NCT04913311 2026-02-19

Predictive Biomarkers for Pneumonitis After Chemoradiotherapy and Immunotherapy in Patients With Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT07256002 2025-12-01

Survival Analysis and Prognostic Biomarker Exploration of Postoperative Adjuvant Therapy Patterns in Patients With Non-small Cell Lung Cancer After Neoadjuvant Immunotherapy

Active not recruiting

10,000 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT05486650 2025-07-14

An Observational Clinical Study of Stereotactic Radiotherapy for Advanced Non-Small Cell Lung Cancer With Stable Disease After PD-1 Inhibitor Treatment

Carcinoma, Non-Small-Cell Lung

NCT07036016 2025-06-25

Interstitial Pneumonitis Associated With EGFR-TKI and Combined With PD-1/PD-L1

67,818 enrolled

Carcinoma, Non-Small-Cell Lung

NCT04977791 2025-05-22

Analysis of Drug Resistance in Immune Checkpoint Inhibitors of Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT06869239 2025-03-11

Prediction of Response to PD-L1 Inhibitor After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer Using Multi-omics-based Liquid Biopsy

Small Cell Lung Carcinoma

NCT06751108 2024-12-27

Impact of Concomitant Use of Steroids and Immune-Checkpoint Inhibitors on Survival Outcomes in NSCLC Patients

Active not recruiting

Carcinoma, Non-Small-Cell Lung

NCT06730503 2024-12-12

Glycoprotein in Immunotherapy Response and Efficacy Prediction of Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT05059951 2024-06-04

CREATE

15,000 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05638425 2022-12-06

Radiotherapy Combined With PD-1 Inhibitors and Chemotherapy in the Treatment of NSCLC Patients With Symptomatic Brain Metastases

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

NCT05326906 2022-05-16

The Prediction Biomarkers of Survival Outcome for Severe Immune-related Hepatitis

Lung Neoplasms

NCT05037825 2022-04-27

PARADIGM

BreastDermatologicGenitourinaryThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Melanoma, Triple Negative Breast Neoplasms

NCT04835025 2021-04-08

Radiotherapy Combined With Immunotherapy for Brain Metastases of Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung

NCT04137588 2021-02-24

Efficacy and Safety of Use of Platinum Based Doublet Chemotherapy Plus Antiangiogenesis and Immune Checkpoint Inhibitors in Patients With Advanced Non-squamous Non-small Cell Lung Cancer

Advanced Non-squamous Non-small Cell Lung Cancer

NCT04629027 2021-02-24

Evaluation System for the Efficacy of Immunologic Checkpoint Inhibitors in NSCLC

Carcinoma, Non-Small-Cell Lung

NCT04115410 2020-05-28

PD-1 Immune Checkpoint Inhibitors and Immune-Related Adverse Events: a Cohort Study

Carcinoma, Non-Small-Cell Lung

NCT04355806 2020-04-21

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Carcinoma, Non-Small-Cell Lung, Influenza, Human